000 01793 a2200577 4500
005 20250515231948.0
264 0 _c20101110
008 201011s 0 0 eng d
022 _a1873-2518
024 7 _a10.1016/j.vaccine.2010.06.086
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTribble, D
245 0 0 _aSafety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers.
_h[electronic resource]
260 _bVaccine
_cAug 2010
300 _a6076-85 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAdministration, Intranasal
650 0 4 _aAdult
650 0 4 _aAnimals
650 0 4 _aAntibody Formation
650 0 4 _aAntibody-Producing Cells
_ximmunology
650 0 4 _aDysentery, Bacillary
_ximmunology
650 0 4 _aFemale
650 0 4 _aGuinea Pigs
650 0 4 _aHumans
650 0 4 _aImmunity, Mucosal
650 0 4 _aImmunization Schedule
650 0 4 _aImmunoglobulin A
_xblood
650 0 4 _aImmunoglobulin G
_xblood
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aShigella Vaccines
_xadverse effects
650 0 4 _aShigella flexneri
_ximmunology
650 0 4 _aYoung Adult
700 1 _aKaminski, R
700 1 _aCantrell, J
700 1 _aNelson, M
700 1 _aPorter, C
700 1 _aBaqar, S
700 1 _aWilliams, C
700 1 _aArora, R
700 1 _aSaunders, J
700 1 _aAnanthakrishnan, M
700 1 _aSanders, J
700 1 _aZaucha, G
700 1 _aTurbyfill, R
700 1 _aOaks, E
773 0 _tVaccine
_gvol. 28
_gno. 37
_gp. 6076-85
856 4 0 _uhttps://doi.org/10.1016/j.vaccine.2010.06.086
_zAvailable from publisher's website
999 _c19962685
_d19962685